BG Klinik Tübingen
- Address
- Schnarrenbergstrasse 95, 72076 Tübingen, Germany
Peripheral Neuropathy Pain
The Pain Medicine department at BG Klinik Tübingen focuses on chronic pain arising from traumatic or post‑operative peripheral neuropathy. Trials aim to evaluate the added benefit and safety of AP707 as an adjunct therapy.
- Assessing pain reduction
- Monitoring tolerability
- Enhancing functional outcomes
These studies contribute to better management strategies for patients with nerve‑injury related pain.
Central Neuropathy Pain
Research at the site explores chronic pain due to central neuropathy of any origin, testing whether AP707 can improve symptom control when used alongside standard care.
- Evaluating efficacy
- Safety profiling
- Patient‑reported outcome measures
Findings aim to broaden therapeutic options for complex neuropathic pain conditions.
Chronic Back Pain
In the field of chronic back pain, investigators assess the potential of AP707 as an add‑on treatment to alleviate persistent discomfort.
- Pain intensity tracking
- Adverse event surveillance
- Impact on daily activities
The work supports efforts to address a leading cause of disability in the region.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Apurano Pharmaceuticals GmbH4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in BG Klinik Tübingen
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain | Apurano Pharmaceuticals GmbH | Phase III | Not Recruiting | Nov 2023 | Mar 2026 |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adezunap | 4 | Unknown | 2023-11-02 | 2023-11-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.